PT  - JOURNAL ARTICLE
AU  - Coltrera, Francesca
ED  - Scagliotti, Giorgio V.
ED  - Mazières, Julien
TI  - Veliparib Plus Platinum Therapy Promising in NSCLC Phase 2 Trial
DP  - 2015 Jun 19
TA  - MD Conference Express
PG  - 11--11
VI  - 15
IP  - 8
4099  - http://mdc.sagepub.com/content/15/8/11.1.short
4100  - http://mdc.sagepub.com/content/15/8/11.1.full
AB  - A trend toward the modest extension of progression-free survival and overall survival was seen in a subgroup of non–small cell lung cancer patients in this phase 2 randomized double-blind trial of veliparib combined with carboplatin and paclitaxel compared with carboplatin and paclitaxel alone.